Suvretta Capital Management LLC raised its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 0.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,423,897 shares of the company’s stock after acquiring an additional 29,000 shares during the period. EyePoint Pharmaceuticals accounts for about 1.6% […]
EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its price objective hoisted by HC Wainwright from $25.00 to $35.00 in a report issued on Tuesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for EyePoint Pharmaceuticals’ Q4 2023 earnings at ($0.43) EPS, FY2023 earnings at ($1.92) EPS, Q1 […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five ratings firms that are presently covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in […]